Basic/Clinical Science Session
Pediatric AKI Is More Than Just a (Creatinine) Number: Challenges and Advances to Care
November 04, 2022 | 02:00 PM - 04:00 PM
Location: W240, Orange County Convention Center, West Building
Session Description
Preventing, diagnosing, and managing AKI can be challenging for pediatric physicians. Small patient size and complex comorbidities often present from birth, and ongoing developmental and maturational changes contribute to the medical complexity of pediatric AKI care. This session highlights the recent improvements to cardiovascular and kidney monitoring in children, including the emergence of novel biomarkers and expanded implementation of quality improvement initiatives.
Learning Objective(s)
- Summarize the challenges in the identification, management, and prevention of AKI in pediatric patients, particularly patients with prematurity and significant comorbidities
- Describe advances in AKI management screening and monitoring in youth
- Report the long-term prognosis of children with history of AKI and identify risk factors for poor prognosis
Learning Pathway(s)
- Pediatric Nephrology
- AKI and Critical Care
Moderators
- Tahagod Mohamed, MD
- Rupesh Raina, MD, FASN
Presentations
- Pediatric AKI: Another Example of How Children Are Not Little Adults
02:00 PM - 02:30 PM
Jeffrey J. Fadrowski, MD, MS
- Advances in the Prevention and Identification of Early AKI: The Role of Biomarkers and Artificial Intelligence
02:30 PM - 03:00 PM
Shina Menon, MD
- Role and Impact of Quality Improvement Initiatives in Pediatric AKI
03:00 PM - 03:30 PM
Stuart Goldstein, MD, FASN
- Kidney Prognosis of Children with AKI
03:30 PM - 04:00 PM
Cherry Mammen, MD
